Veraxa Biotech AG rStock

RVRXA

Veraxa Biotech is a Switzerland-based, pre-clinical and early clinical-stage biopharmaceutical company leveraging its proprietary BiTAC platform and high-throughput single-cell screening system to develop next-generation bispecific T-cell engagers (TCEs) and antibody-drug conjugates (ADCs) for solid and hematological tumors.